Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics
Authors
Keywords
Neurotransmitter, Neurotransmission, Parkinson's disease, Neurodegeneration
Journal
NEUROCHEMISTRY INTERNATIONAL
Volume 156, Issue -, Pages 105327
Publisher
Elsevier BV
Online
2022-03-21
DOI
10.1016/j.neuint.2022.105327
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of striatal dopamine D5 receptor attenuates levodopa-induced dyskinesia in a rat model of Parkinson’s disease
- (2021) Yong Wang et al. BRAIN RESEARCH
- Metabotropic glutamate receptor 5 inhibits α-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson’s disease
- (2021) Ya-Nan Zhang et al. Journal of Neuroinflammation
- α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss
- (2021) Dorit Trudler et al. JOURNAL OF NEUROSCIENCE
- Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer’s disease
- (2021) Luke Whiley et al. Alzheimers Research & Therapy
- Enhanced GABAergic Inhibition of Cholinergic Interneurons in the zQ175+/− Mouse Model of Huntington's Disease
- (2021) Sean Austin O. Lim et al. Frontiers in Systems Neuroscience
- Sympathetic and sensory nerve fiber function in multiple system atrophy and idiopathic Parkinson’s disease
- (2021) Heidrun H. Krämer et al. JOURNAL OF NEUROLOGY
- Discovery and optimization of a novel CNS penetrant series of mGlu4 PAMs based on a 1,4-thiazepane core with in vivo efficacy in a preclinical Parkinsonian model
- (2021) Caitlin N. Kent et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Norepinephrine reuptake blockade to treat neurogenic orthostatic hypotension
- (2021) Graeme Eisenhofer et al. CLINICAL AUTONOMIC RESEARCH
- The cell biology of Parkinson’s disease
- (2021) Nikhil Panicker et al. JOURNAL OF CELL BIOLOGY
- Early differences in membrane properties at the neuromuscular junctions of ALS model mice: Effects of 25-hydroxycholesterol
- (2021) Guzel F. Zakyrjanova et al. LIFE SCIENCES
- Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA‐FLUO Trial
- (2021) Olivier Rascol et al. MOVEMENT DISORDERS
- Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease
- (2021) Thomas Kremer et al. MOVEMENT DISORDERS
- Spatial Covariance of Cholinergic Muscarinic M 1 / M 4 Receptors in Parkinson's Disease
- (2021) Sean J. Colloby et al. MOVEMENT DISORDERS
- Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis
- (2021) Giulia Fiscon et al. Neurotherapeutics
- Reduction of falls in a rat model of PD falls by the M1 PAM TAK-071
- (2021) Aaron Kucinski et al. PSYCHOPHARMACOLOGY
- Reduced acetylcholine and elevated muscarinic receptor 2 in duodenal mucosa contribute to the impairment of mucus secretion in 6-hydroxydopamine-induced Parkinson’s disease rats
- (2021) Jing-Ting Yan et al. CELL AND TISSUE RESEARCH
- mGluR2/3 Activation Improves Motor Performance and Reduces Pathology in heterozygous zQ175 Huntington's Disease Mice
- (2021) Si Han Li et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Glutamate Delta-1 Receptor Regulates Inhibitory Neurotransmission in the Nucleus Accumbens Core and Anxiety-Like Behaviors
- (2021) Dinesh Y. Gawande et al. MOLECULAR NEUROBIOLOGY
- Blockade of pre-synaptic and post-synaptic GABAB receptors in the lateral habenula produces different effects on anxiety-like behaviors in 6-hydroxydopamine hemiparkinsonian rats
- (2021) Yaxin Yang et al. NEUROPHARMACOLOGY
- Structural determinants and regulation of spontaneous activity in GABAA receptors
- (2021) Craig A. Sexton et al. Nature Communications
- BACHD Mice Recapitulate the Striatal Parvalbuminergic Interneuron Loss Found in Huntington’s Disease
- (2021) Vyshnavi Rallapalle et al. Frontiers in Neuroanatomy
- TDP-43 regulates GAD1 mRNA splicing and GABA signaling in Drosophila CNS
- (2021) Giulia Romano et al. Scientific Reports
- Human amyotrophic lateral sclerosis excitability phenotype screen: Target discovery and validation
- (2021) Xuan Huang et al. Cell Reports
- Multiplatform metabolomic analysis of the R6/2 mouse model of Huntington’s disease
- (2021) Masayo Hashimoto et al. FEBS Open Bio
- Monoamine Levels and Parkinson’s Disease Progression: Evidence From a High-Performance Liquid Chromatography Study
- (2021) Patsorn Wichit et al. Frontiers in Neuroscience
- Cholinergic Receptor Modulation as a Target for Preventing Dementia in Parkinson’s Disease
- (2021) Alexandre Iarkov et al. Frontiers in Neuroscience
- Striatal Synapse Degeneration and Dysfunction Are Reversed by Reactivation of Wnt Signaling
- (2021) Soledad Galli et al. Frontiers in Synaptic Neuroscience
- Video Representation of Dopamine-Responsive Multiple System Atrophy Cerebellar Type
- (2021) Jonathan Doan et al. American Journal of Case Reports
- Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease
- (2020) Cynthia Kwan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Implication of 5-HT in the Dysregulation of Chloride Homeostasis in Prenatal Spinal Motoneurons from the G93A Mouse Model of Amyotrophic Lateral Sclerosis
- (2020) Elodie Martin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Reduced Hippocampal Glutamate and Posterior Cingulate N-Acetyl Aspartate in Mild Cognitive Impairment and Alzheimer’s Disease Is Associated with Episodic Memory Performance and White Matter Integrity in the Cingulum: A Pilot Study
- (2020) Dickson Wong et al. JOURNAL OF ALZHEIMERS DISEASE
- D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson’s disease
- (2020) Irene Sebastianutto et al. JOURNAL OF CLINICAL INVESTIGATION
- Genes to treat excitotoxicity ameliorate the symptoms of the disease in mice models of multiple system atrophy
- (2020) Micaela Johanna Glat et al. JOURNAL OF NEURAL TRANSMISSION
- Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy
- (2020) Mohammad Shahnawaz et al. NATURE
- Distinct anti-dyskinetic effects of amantadine and group II metabotropic glutamate receptor agonist LY354740 in a rodent model: An electrophysiological perspective
- (2020) Cong Zheng et al. NEUROBIOLOGY OF DISEASE
- Neuron-glia interaction through Serotonin-BDNF-NGFR axis enables regenerative neurogenesis in Alzheimer’s model of adult zebrafish brain
- (2020) Prabesh Bhattarai et al. PLOS BIOLOGY
- Circulating Glutamine and Alzheimer’s Disease: A Mendelian Randomization Study
- (2020) Charleen D Adams Clinical Interventions in Aging
- LY354740 Reduces Extracellular Glutamate Concentration, Inhibits Phosphorylation of Fyn/NMDARs, and Expression of PLK2/pS129 α-Synuclein in Mice Treated With Acute or Sub-Acute MPTP
- (2020) Yang Tan et al. Frontiers in Pharmacology
- Deficits in coordinated neuronal activity and network topology are striatal hallmarks in Huntington’s disease
- (2020) S. Fernández-García et al. BMC BIOLOGY
- Cortical interneuron-mediated inhibition delays the onset of amyotrophic lateral sclerosis
- (2020) C Sahara Khademullah et al. BRAIN
- Mechanisms underlying unawareness of neurogenic orthostatic hypotension
- (2020) Philip W. Tipton et al. CLINICAL AUTONOMIC RESEARCH
- Selective metabotropic glutamate receptor 2 positive allosteric modulation alleviates L-DOPA-induced psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset
- (2020) Lamia Sid-Otmane et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Serotonin in Health and Disease
- (2020) Philippe De Deurwaerdère et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Antidopaminergic treatment is associated with reduced chorea and irritability but impaired cognition in Huntington’s disease (Enroll-HD)
- (2020) Kate L Harris et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Structures of α-synuclein filaments from multiple system atrophy
- (2020) Manuel Schweighauser et al. NATURE
- The selective 5-HT1A receptor agonist, NLX-112, exerts anti-dyskinetic and anti-parkinsonian-like effects in MPTP-treated marmosets
- (2020) Ria Fisher et al. NEUROPHARMACOLOGY
- NMDA receptors are altered in the substantia nigra pars reticulata and their blockade ameliorates motor deficits in experimental parkinsonism
- (2020) Giacomo Sitzia et al. NEUROPHARMACOLOGY
- Complementarity of gluCEST and 1 H-MRS for the study of mouse models of Huntington's disease
- (2020) Jérémy Pépin et al. NMR IN BIOMEDICINE
- Norepinephrine is a negative regulator of the adult periventricular neural stem cell niche
- (2020) Grit Weselek et al. STEM CELLS
- Astrocytes with TDP-43 inclusions exhibit reduced noradrenergic cAMP and Ca2+ signaling and dysregulated cell metabolism
- (2020) Jelena Velebit et al. Scientific Reports
- Antiparkinsonian Effects of a Metabotropic Glutamate Receptor 4 Agonist in MPTP-Treated Marmosets
- (2020) Elizabeth Mann et al. Journal of Parkinsons Disease
- D1 Dopamine Receptor Activation Induces Neuronal eEF2 Pathway-Dependent Protein Synthesis
- (2020) Orit David et al. Frontiers in Molecular Neuroscience
- Striatal Dopamine D2-Muscarinic Acetylcholine M1 Receptor–Receptor Interaction in a Model of Movement Disorders
- (2020) René A. J. Crans et al. Frontiers in Pharmacology
- Circular Dichroism Spectroscopy Identifies the β-Adrenoceptor Agonist Salbutamol As a Direct Inhibitor of Tau Filament Formation in Vitro
- (2020) David J Townsend et al. ACS Chemical Neuroscience
- NCX1 and EAAC1 transporters are involved in the protective action of glutamate in an in vitro Alzheimer's disease-like model
- (2020) Simona Magi et al. CELL CALCIUM
- β-Adrenoceptor Drugs and Parkinson’s Disease: A Nationwide Nested Case–Control Study
- (2020) Sibylle de Germay et al. CNS DRUGS
- Dopamine depletion induces neuron‐specific alterations of GABAergic transmission in the mouse striatum
- (2020) Ida Luisa Boccalaro et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Roles of glutamate receptors in a novel in vitro model of early, comorbid cerebrovascular and Alzheimer’s diseases
- (2020) Elisa N. Simões‐Pires et al. JOURNAL OF NEUROCHEMISTRY
- Cerebral Dopamine Neurotrophic Factor Regulates Multiple Neuronal Subtypes and Behavior
- (2020) Yu-Chia Chen et al. JOURNAL OF NEUROSCIENCE
- Expression levels of the α7 nicotinic acetylcholine receptor in the brains of patients with Alzheimer's disease and their effect on synaptic proteins in SH-SY5Y cells
- (2020) Jia-Mou Ren et al. Molecular Medicine Reports
- Genetic lack of histamine upregulates dopamine neurotransmission and alters rotational behavior but not levodopa-induced dyskinesia in a mouse model of Parkinson’s disease
- (2020) Sini K. Koski et al. NEUROSCIENCE LETTERS
- 5-HT2A/B receptor expression in the phrenic motor nucleus in a rat model of ALS (SOD1G93A)
- (2020) Lauren F. Borkowski et al. RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
- Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease
- (2020) David Moreno-Delgado et al. eLife
- Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation
- (2020) Rouba Kozak et al. Frontiers in Pharmacology
- Dopamine-mediated improvements in dynamic balance control in Parkinson’s disease
- (2020) Daniel J Kuhman et al. GAIT & POSTURE
- Neuroprotective Effect of Curcumin on the Nigrostriatal Pathway in a 6-Hydroxydopmine-Induced Rat Model of Parkinson’s Disease is Mediated by α7-Nicotinic Receptors
- (2020) Eslam El Nebrisi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ascorbate deficiency decreases dopamine release in gulo –/– and APP/PSEN1 mice
- (2020) David C. Consoli et al. JOURNAL OF NEUROCHEMISTRY
- Reactive Oxygen Species Modulate Activity-Dependent AMPA Receptor Transport in C. elegans
- (2020) Rachel L. Doser et al. JOURNAL OF NEUROSCIENCE
- Mechanisms underlying the enhancement of γ‐aminobutyric acid responses in the external globus pallidus of R6/2 Huntington’s disease model mice
- (2020) Joshua Barry et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Combination of acamprosate and baclofen (PXT864) as a potential new therapy for amyotrophic lateral sclerosis
- (2020) Lydie Boussicault et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Brain 5‐HT1A Receptor Binding in Multiple System Atrophy: An [ 18 F ]‐ MPPF PET Study
- (2020) Marie Meyer et al. MOVEMENT DISORDERS
- GABA storage and release in the medial globus pallidus in L-DOPA-induced dyskinesia priming
- (2020) Haruo Nishijima et al. NEUROBIOLOGY OF DISEASE
- Kukoamine A Protects against NMDA-Induced Neurotoxicity Accompanied with Down-Regulation of GluN2B-Containing NMDA Receptors and Phosphorylation of PI3K/Akt/GSK-3β Signaling Pathway in Cultured Primary Cortical Neurons
- (2020) Yue Yang et al. NEUROCHEMICAL RESEARCH
- Pepper component 7-ethoxy-4-methylcoumarin, a novel dopamine D2 receptor agonist, ameliorates experimental Parkinson’s disease in mice and Caenorhabditis elegans
- (2020) Hongli Li et al. PHARMACOLOGICAL RESEARCH
- Protease-activated receptor 1 (PAR1) inhibits synaptic NMDARs in mouse nigral dopaminergic neurons
- (2020) Rachel Price et al. PHARMACOLOGICAL RESEARCH
- Rapid drug increase and early onset of levodopa-induced dyskinesia in Parkinson’s disease
- (2020) Jin Yong Hong et al. PLoS One
- Microglia modulate neurodegeneration in Alzheimer’s and Parkinson’s diseases
- (2020) Tim Bartels et al. SCIENCE
- M2 cortex-dorsolateral striatum stimulation reverses motor symptoms and synaptic deficits in Huntington’s disease
- (2020) Sara Fernández-García et al. eLife
- Antiallergic drug desloratadine as a selective antagonist of 5HT 2A receptor ameliorates pathology of Alzheimer's disease model mice by improving microglial dysfunction
- (2020) Jian Lu et al. AGING CELL
- Activation and blockade of 5-HT6 receptor in the medial septum-diagonal band recover working memory in the hemiparkinsonian rats
- (2020) Libo Li et al. BRAIN RESEARCH
- Blockade of metabotropic glutamate receptor 5 attenuates axonal degeneration in 6-hydroxydopamine-induced model of Parkinson's disease
- (2020) Jian-Nan Zhang et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Blockade of GABA transporter-1 and GABA transporter-3 in the lateral habenula improves depressive-like behaviors in a rat model of Parkinson's disease
- (2020) Shuxuan Lyu et al. NEUROPHARMACOLOGY
- Serotonin research: Crossing scales and boundaries
- (2020) Giuseppe Di Giovanni et al. NEUROPHARMACOLOGY
- Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection
- (2020) Ryo Kikuoka et al. Scientific Reports
- New information of dopaminergic agents based on quantum chemistry calculations
- (2020) Guillermo Goode-Romero et al. Scientific Reports
- Dopamine D1 + D3 receptor density may correlate with parkinson disease clinical features
- (2020) Pengfei Yang et al. Annals of Clinical and Translational Neurology
- Histamine-4 receptor antagonist ameliorates Parkinson-like pathology in the striatum
- (2020) Qiuyuan Fang et al. BRAIN BEHAVIOR AND IMMUNITY
- Genetic suppression of the dopamine D3 receptor in striatal D1 cells reduces the development of L-DOPA-induced dyskinesia
- (2020) Kathryn Lanza et al. EXPERIMENTAL NEUROLOGY
- Effectiveness of Levodopa in Patients with Multiple System Atrophy and Associated Clinicopathological Features
- (2020) Chiho Ishida et al. INTERNAL MEDICINE
- Beta2-Adrenoceptor Agonists in Parkinson’s Disease and Other Synucleinopathies
- (2019) Luca Magistrelli et al. Journal of Neuroimmune Pharmacology
- From beta-blockers to Parkinson's disease in respect of essential tremor
- (2019) Katarina Vogelnik et al. MOVEMENT DISORDERS
- Cholinergic Interneurons Amplify Thalamostriatal Excitation of Striatal Indirect Pathway Neurons in Parkinson’s Disease Models
- (2019) Asami Tanimura et al. NEURON
- Alterations in GABAA-Receptor Trafficking and Synaptic Dysfunction in Brain Disorders
- (2019) Miranda Mele et al. Frontiers in Cellular Neuroscience
- Chronic administration of the histamine H3 receptor agonist immepip decreases l-Dopa-induced dyskinesias in 6-hydroxydopamine-lesioned rats
- (2019) Alberto Avila-Luna et al. PSYCHOPHARMACOLOGY
- Circuit Mechanisms of Parkinson’s Disease
- (2019) Matthew M. McGregor et al. NEURON
- Enhanced striatopallidal gamma‐aminobutyric acid (GABA) A receptor transmission in mouse models of huntington's disease
- (2019) Tamara Perez‐Rosello et al. MOVEMENT DISORDERS
- Adrenoceptor agonists and antagonists and risk of Parkinson's disease
- (2019) Helia Maghzi et al. MOVEMENT DISORDERS
- Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration
- (2019) Valentina Durante et al. BRAIN
- Dopaminergic modulation of striatal function and Parkinson’s disease
- (2019) Shenyu Zhai et al. JOURNAL OF NEURAL TRANSMISSION
- Presynaptic striatal dopaminergic function in atypical parkinsonisms: A meta-analysis of imaging studies
- (2019) Valtteri Kaasinen et al. JOURNAL OF NUCLEAR MEDICINE
- EGF Treatment Improves Motor Behavior and Cortical GABAergic Function in the R6/2 Mouse Model of Huntington’s Disease
- (2019) Felecia M. Marottoli et al. MOLECULAR NEUROBIOLOGY
- Activation and blockade of dorsal hippocampal Serotonin6 receptors regulate anxiety-like behaviors in a unilateral 6-hydroxydopamine rat model of Parkinson’s disease
- (2019) Kun Cheng Liu et al. NEUROLOGICAL RESEARCH
- Alterations in Hippocampal Inhibitory Synaptic Transmission in the R6/2 Mouse Model of Huntington’s Disease
- (2019) Zahra Dargaei et al. NEUROSCIENCE
- Histaminergic transmission slows progression of amyotrophic lateral sclerosis
- (2019) Savina Apolloni et al. Journal of Cachexia Sarcopenia and Muscle
- Ginsenoside Rb1 regulates prefrontal cortical GABAergic transmission in MPTP-treated mice
- (2019) Yan Liu et al. Aging-US
- Pathophysiological clues to therapeutic applications of glutamate mGlu5 receptor antagonists in levodopa-induced dyskinesia
- (2019) Shayan Pourmirbabaei et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Membralin deficiency dysregulates astrocytic glutamate homeostasis, leading to ALS-like impairment
- (2019) Lu-Lin Jiang et al. JOURNAL OF CLINICAL INVESTIGATION
- Longitudinal PET Imaging of α7 Nicotinic Acetylcholine Receptors with [18F]ASEM in a Rat Model of Parkinson’s Disease
- (2019) Steven Vetel et al. MOLECULAR IMAGING AND BIOLOGY
- Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson's disease
- (2019) Samira Ztaou et al. NEUROCHEMISTRY INTERNATIONAL
- Dopamine Deficiency Reduces Striatal Cholinergic Interneuron Function in Models of Parkinson’s Disease
- (2019) Jonathan W. McKinley et al. NEURON
- Effects of Muscarinic Acetylcholine m1 and m4 Receptor Blockade on Dyskinesia in the Hemi-Parkinsonian Rat
- (2019) Nicole E. Chambers et al. NEUROSCIENCE
- Parkinson’s Disease in Women and Men: What’s the Difference?
- (2019) Silvia Cerri et al. Journal of Parkinsons Disease
- Dopamine Receptor D3 Expression Is Altered in CD4+ T-Cells From Parkinson's Disease Patients and Its Pharmacologic Inhibition Attenuates the Motor Impairment in a Mouse Model
- (2019) Daniela Elgueta et al. Frontiers in Immunology
- Intranasal Administration of Mesenchymal Stem Cells Ameliorates the Abnormal Dopamine Transmission System and Inflammatory Reaction in the R6/2 Mouse Model of Huntington Disease
- (2019) Libo Yu-Taeger et al. Cells
- Lifelong choline supplementation ameliorates Alzheimer’s disease pathology and associated cognitive deficits by attenuating microglia activation
- (2019) Ramon Velazquez et al. AGING CELL
- Activation and blockade of α2-adrenoceptors in the prelimbic cortex regulate anxiety-like behaviors in hemiparkinsonian rats
- (2019) Zhongheng Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrain
- (2019) Sandy Stayte et al. EXPERIMENTAL NEUROLOGY
- Histamine Is an Inducer of the Heat Shock Response in SOD1-G93A Models of ALS
- (2019) Savina Apolloni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis during Disease Progression
- (2019) Tiziana Bonifacino et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Selective Regulation of 5-HT1B Serotonin Receptor Expression in the Striatum by Dopamine Depletion and Repeated L-DOPA Treatment: Relationship to L-DOPA-Induced Dyskinesias
- (2019) Fernando E. Padovan-Neto et al. MOLECULAR NEUROBIOLOGY
- Pharmacological antagonism of histamine H2R ameliorated L-DOPA–induced dyskinesia via normalization of GRK3 and by suppressing FosB and ERK in PD
- (2019) Mohamed Rafiuddin Ahmed et al. NEUROBIOLOGY OF AGING
- Preserved Serotonergic Activity in Early-Onset Parkinson’s Disease
- (2019) Hee Kyung Park et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- GABAergic changes in the thalamocortical circuit in Parkinson's disease
- (2019) Annelies J. M. Nuland et al. HUMAN BRAIN MAPPING
- Serotonin 5-HT4 Receptor Agonists Improve Facilitation of Contextual Fear Extinction in An MPTP-Induced Mouse Model of Parkinson’s Disease
- (2019) Ishii et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Neurotransmitter Imbalance in the Brain and Alzheimer’s Disease Pathology
- (2019) Stuart G. Snowden et al. JOURNAL OF ALZHEIMERS DISEASE
- mGluR5 Allosteric Modulation Promotes Neurorecovery in a 6-OHDA-Toxicant Model of Parkinson’s Disease
- (2019) Kyle Farmer et al. MOLECULAR NEUROBIOLOGY
- Differential enhancement of ERK, PKA and Ca2+ signaling in direct and indirect striatal neurons of Parkinsonian mice
- (2019) Louise-Laure Mariani et al. NEUROBIOLOGY OF DISEASE
- Blockade of calcium-permeable AMPA receptors in the lateral habenula produces increased antidepressant-like effects in unilateral 6-hydroxydopamine-lesioned rats compared to sham-lesioned rats
- (2019) Jin Zhang et al. NEUROPHARMACOLOGY
- Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism
- (2019) Imane Frouni et al. NEUROPHARMACOLOGY
- Rescuing the attentional performance of rats with cholinergic losses by the M1 positive allosteric modulator TAK-071
- (2019) Aaron Kucinski et al. PSYCHOPHARMACOLOGY
- Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?
- (2019) Pengfei Yang et al. AGEING RESEARCH REVIEWS
- Dopamine D1 receptor agonism induces dynamin related protein-1 inhibition to improve mitochondrial biogenesis and dopaminergic neurogenesis in rat model of Parkinson’s disease
- (2019) Akanksha Mishra et al. BEHAVIOURAL BRAIN RESEARCH
- Serotonin1A receptors in the dorsal hippocampus regulate working memory and long-term habituation in the hemiparkinsonian rats
- (2019) Ye Liu et al. BEHAVIOURAL BRAIN RESEARCH
- Histamine Induces Microglia Activation and the Release of Proinflammatory Mediators in Rat Brain Via H1R or H4R
- (2019) Wei Zhang et al. Journal of Neuroimmune Pharmacology
- SIRT3 Haploinsufficiency Aggravates Loss of GABAergic Interneurons and Neuronal Network Hyperexcitability in an Alzheimer's Disease Model
- (2019) Aiwu Cheng et al. JOURNAL OF NEUROSCIENCE
- Cerebral dopamine neurotrophic factor–deficiency leads to degeneration of enteric neurons and altered brain dopamine neuronal function in mice
- (2019) Maria Lindahl et al. NEUROBIOLOGY OF DISEASE
- The physiology and pathophysiology of basal ganglia: From signal transduction to circuits
- (2019) Nao Chuhma et al. NEUROCHEMISTRY INTERNATIONAL
- Norepinephrine upregulates the expression of tyrosine hydroxylase and protects dopaminegic neurons against 6-hydrodopamine toxicity
- (2019) Meng-Yang Zhu et al. NEUROCHEMISTRY INTERNATIONAL
- Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of β-arrestin2 and NLRP3
- (2018) Jialei Zhu et al. CELL DEATH AND DIFFERENTIATION
- Insight into the emerging role of striatal neurotransmitters in the pathophysiology of Parkinson’s disease and Huntington’s disease: A review
- (2018) Sumit Jamwal et al. Current Neuropharmacology
- Oscillatory activity in the cortico-basal ganglia-thalamic neural circuits in Parkinson's disease
- (2018) Arun Singh EUROPEAN JOURNAL OF NEUROSCIENCE
- Curcumin Acts as a Positive Allosteric Modulator ofα7-Nicotinic Acetylcholine Receptors and Reverses Nociception in Mouse Models of Inflammatory Pain
- (2018) Eslam Gaber El Nebrisi et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Involvement of prelimbic 5-HT7 receptors in the regulation of anxiety-like behaviors in hemiparkinsonian rats
- (2018) Cheng Xue Du et al. NEUROLOGICAL RESEARCH
- Increased Cholinergic Response in α-Synuclein Transgenic Mice (h-α-synL62)
- (2018) Magdalena König et al. ACS Chemical Neuroscience
- Striatal cholinergic interneurons regulates cognitive and affective dysfunction in partially dopamine depleted mice
- (2018) Samira Ztaou et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- 18F-FPEB PET/CT Shows mGluR5 Upregulation in Parkinson's Disease
- (2018) Yeona Kang et al. JOURNAL OF NEUROIMAGING
- Beyond Dopamine: GABA, Glutamate, and the Axial Symptoms of Parkinson Disease
- (2018) Ruth L. O'Gorman Tuura et al. Frontiers in Neurology
- Histamine-4 receptor antagonist JNJ7777120 inhibits pro-inflammatory microglia and prevents the progression of Parkinson-like pathology and behaviour in a rat model
- (2018) Pei Zhou et al. BRAIN BEHAVIOR AND IMMUNITY
- Striatal GABA ergic interneuron dysfunction in the Q175 mouse model of Huntington's disease
- (2018) Sandra M. Holley et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients
- (2018) Adrienne Müller Herde et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Inhibition of nigrostriatal dopamine release by striatal GABAA and GABAB receptors
- (2018) Emanuel F. Lopes et al. JOURNAL OF NEUROSCIENCE
- Pridopidine, a clinic-ready compound, reduces 3,4-dihydroxyphenylalanine-induced dyskinesia in Parkinsonian macaques
- (2018) Tom H. Johnston et al. MOVEMENT DISORDERS
- Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications
- (2018) Alberto J. Espay et al. MOVEMENT DISORDERS
- Dopamine D1 receptor activation improves adult hippocampal neurogenesis and exerts anxiolytic and antidepressant-like effect via activation of Wnt/β-catenin pathways in rat model of Parkinson's disease
- (2018) Akanksha Mishra et al. NEUROCHEMISTRY INTERNATIONAL
- Clinical characteristics and quality of life in Chinese patients with multiple system atrophy
- (2018) Juan-Juan Du et al. Brain and Behavior
- Investigational dopamine antagonists for the treatment of schizophrenia
- (2017) Sheng-Min Wang et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Rolipram improves facilitation of contextual fear extinction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease
- (2017) Ken-ichi Kinoshita et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- 18 F-fallypride PET-CT of dopamine D2/D3 receptors in patients with sporadic amyotrophic lateral sclerosis
- (2017) Xiaoling Fu et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Homovanillic acid in CSF of mild stage Parkinson's disease patients correlates with motor impairment
- (2017) Alessandro Stefani et al. NEUROCHEMISTRY INTERNATIONAL
- Involvement of lateral habenula α1 subunit-containing GABA A receptor-mediated inhibitory transmission in the regulation of depression-related behaviors in experimental Parkinson's disease
- (2017) Tao Wang et al. NEUROPHARMACOLOGY
- The impact of metabotropic glutamate receptors into active neurodegenerative processes: A “dark side” in the development of new symptomatic treatments for neurologic and psychiatric disorders
- (2017) Valeria Bruno et al. NEUROPHARMACOLOGY
- Metabotropic glutamate receptors and neurodegenerative diseases
- (2017) Fabiola M. Ribeiro et al. PHARMACOLOGICAL RESEARCH
- Dopamine acting at D1-like, D2-like and α1-adrenergic receptors differentially modulates theta and gamma oscillatory activity in primary motor cortex
- (2017) Mazhar Özkan et al. PLoS One
- Neurotransmission systems in Parkinson’s disease
- (2017) Hossein Sanjari Moghaddam et al. REVIEWS IN THE NEUROSCIENCES
- β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease
- (2017) Shuchi Mittal et al. SCIENCE
- Premotor Diagnosis of Parkinson’s Disease
- (2017) Heinz Reichmann Neuroscience Bulletin
- The histamine H3 receptor antagonist thioperamide rescues circadian rhythm and memory function in experimental parkinsonism
- (2017) D Masini et al. Translational Psychiatry
- The Basal Ganglia Over 500 Million Years
- (2016) Sten Grillner et al. CURRENT BIOLOGY
- Muscarinic receptor binding changes in postmortem Parkinson’s disease
- (2016) Caitlin McOmish et al. JOURNAL OF NEURAL TRANSMISSION
- Parkinson’s: a syndrome rather than a disease?
- (2016) Nataliya Titova et al. JOURNAL OF NEURAL TRANSMISSION
- Histamine induces microglia activation and dopaminergic neuronal toxicity via H1 receptor activation
- (2016) Sandra M. Rocha et al. Journal of Neuroinflammation
- Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease
- (2016) S. Ztaou et al. JOURNAL OF NEUROSCIENCE
- Cholinergic and perfusion brain networks in Parkinson disease dementia
- (2016) Sean J. Colloby et al. NEUROLOGY
- The Basal Ganglia in Action
- (2016) Henry H. Yin NEUROSCIENTIST
- Muscarinic M1 Receptor Coupling to G-protein is Intact in Parkinson’s Disease Dementia
- (2016) Jasinda H. Lee et al. Journal of Parkinsons Disease
- 5-HT2AReceptor Binding in the Frontal Cortex of Parkinson’s Disease Patients and Alpha-Synuclein Overexpressing Mice: A Postmortem Study
- (2016) Nadja Bredo Rasmussen et al. Parkinsons Disease
- Serotonin in Parkinson's disease
- (2015) Marios Politis et al. BEHAVIOURAL BRAIN RESEARCH
- The effects of sigma (σ1) receptor-selective ligands on muscarinic receptor antagonist-induced cognitive deficits in mice
- (2015) Maninder Malik et al. BRITISH JOURNAL OF PHARMACOLOGY
- Possible role of GABA-B receptor modulation in MPTP induced Parkinson's disease in rats
- (2015) Ravi Kant Tyagi et al. EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
- Role of the Indirect Pathway of the Basal Ganglia in Perceptual Decision Making
- (2015) W. Wei et al. JOURNAL OF NEUROSCIENCE
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- Histaminergic tuberomammillary neuron loss in multiple system atrophy and dementia with Lewy bodies
- (2015) Eduardo E. Benarroch et al. MOVEMENT DISORDERS
- M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia
- (2015) Weixing Shen et al. NEURON
- Activity of serotonin 5-HT1A receptor ‘biased agonists’ in rat models of Parkinson's disease and l-DOPA-induced dyskinesia
- (2015) H. Iderberg et al. NEUROPHARMACOLOGY
- Neurotransmitter receptor density changes in Pitx3ak mice – A model relevant to Parkinson’s disease
- (2015) J.N. Cremer et al. NEUROSCIENCE
- The human histaminergic system in neuropsychiatric disorders
- (2015) Ling Shan et al. TRENDS IN NEUROSCIENCES
- α2-Adrenoceptors in the treatment of major neuropsychiatric disorders
- (2015) Salomon Z. Langer TRENDS IN PHARMACOLOGICAL SCIENCES
- The Concept of Prodromal Parkinson’s Disease
- (2015) Philipp Mahlknecht et al. Journal of Parkinsons Disease
- Basal Ganglia Circuits as Targets for Neuromodulation in Parkinson Disease
- (2015) Mahlon R. DeLong et al. JAMA Neurology
- Anti-Parkinson effects of a selective alpha2C-adrenoceptor antagonist in the MPTP marmoset model
- (2014) Ingrid H.C.H.M. Philippens et al. BEHAVIOURAL BRAIN RESEARCH
- Direct and indirect pathways of basal ganglia: a critical reappraisal
- (2014) Paolo Calabresi et al. NATURE NEUROSCIENCE
- Parkin regulates kainate receptors by interacting with the GluK2 subunit
- (2014) AnnaMaria Maraschi et al. Nature Communications
- Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
- (2013) Jeffrey Cummings et al. LANCET
- Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems
- (2013) Lars Brichta et al. TRENDS IN NEUROSCIENCES
- Functional Neuroanatomy of the Basal Ganglia
- (2013) J. L. Lanciego et al. Cold Spring Harbor Perspectives in Medicine
- Cholinergic Receptor Alterations in the Brain Stem of Spinal Cord Injured Rats
- (2012) Chinthu Romeo et al. NEUROCHEMICAL RESEARCH
- Neuromodulation of Brain States
- (2012) Seung-Hee Lee et al. NEURON
- The role of the GABAB receptor and calcium channels in a Drosophila model of Parkinson's Disease
- (2012) Ralph Hillman et al. NEUROSCIENCE LETTERS
- Basal ganglia circuits changes in Parkinson's disease patients
- (2012) Tao Wu et al. NEUROSCIENCE LETTERS
- GABA-B receptor: Possible target for Parkinson's disease therapy
- (2011) Atsushi Nambu EXPERIMENTAL NEUROLOGY
- Changes in the mRNA Levels of α2A and α2C Adrenergic Receptors in Rat Models of Parkinson’s Disease and l-DOPA-Induced Dyskinesia
- (2011) Amal Alachkar et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Etiology and pathogenesis of Parkinson's disease
- (2011) Anthony H. Schapira et al. MOVEMENT DISORDERS
- Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats
- (2011) Christopher J. Barnum et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: An overview of preclinical and clinical findings
- (2011) Susanne Graef et al. PSYCHOPHARMACOLOGY
- Effect of histamine H2receptor antagonism on levodopa-induced dyskinesia in the MPTP-macaque model of Parkinson's disease
- (2010) Tom H. Johnston et al. MOVEMENT DISORDERS
- Metabotropic glutamate receptors: From the workbench to the bedside
- (2010) F. Nicoletti et al. NEUROPHARMACOLOGY
- The Expanded Biology of Serotonin
- (2009) Miles Berger et al. Annual Review of Medicine
- The locus coeruleus and noradrenergic modulation of cognition
- (2009) Susan J. Sara NATURE REVIEWS NEUROSCIENCE
- Genetic variability of histamine receptors in patients with Parkinson's disease
- (2008) Elena García-Martín et al. BMC Medical Genetics
- Parkinson's disease: clinical features and diagnosis
- (2008) J Jankovic JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease
- (2008) Jose A. Obeso et al. MOVEMENT DISORDERS
- Striatal Plasticity and Basal Ganglia Circuit Function
- (2008) Anatol C. Kreitzer et al. NEURON
- Noradrenergic stimulation of BDNF synthesis in astrocytes: Mediation via α1- and β1/β2-adrenergic receptors
- (2007) Damijana Mojca Jurič et al. NEUROCHEMISTRY INTERNATIONAL
- Histamine and its receptors
- (2006) Mike E Parsons et al. BRITISH JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now